Filing Details
- Accession Number:
- 0001048477-24-000073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-06 16:40:49
- Reporting Period:
- 2024-05-02
- Accepted Time:
- 2024-05-06 16:40:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557533 | Robert Jeffrey Ajer | C/O Biomarin Pharmaceutical Inc. 770 Lindaro Street San Rafael CA 94901 | Evp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-30 | 300 | $68.65 | 71,767 | No | 5 | A | Direct | |
| Common Stock | Disposition | 2024-05-02 | 5,000 | $82.91 | 66,767 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.
- Trade made pursuant to a 10b5-1 plan executed on April 13, 2023.
Billionaire Hedge Funds
